Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)

Published:2002-04-22 Issue: Volume: Page:
ISSN:
Container-title:Cochrane Database of Systematic Reviews
language:
Short-container-title:

Author:

Miller RG,Mitchell JD,Lyon M,Moore DH

Publisher

John Wiley & Sons, Ltd

Reference33 articles.

1. A controlled trial of riluzole in amyotrophic lateral sclerosis;Bensimon;New England Journal of Medicine,1994

2. A study of riluzole in the treatment of advanced stage or elderly patients with amyotrophic lateral sclerosis;Bensimon;Journal of Neurology,2002

3. Meininger V Lacomblez L Bensimon G Unpublished report: controlled trial of riluzole in patients with advanced ALS RP 54272-302 1995

4. Dose-ranging study of riluzole in amyotrophic lateral sclerosis;LaComblez;Lancet,1996

5. Open label study of riluzole for the treatment of amyotrophic lateral sclerosis;Arriada-Mendicoa;Revista Ecuatoriana de Neurologia,1999

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A selective review of inhibitors of protein kinase C gamma: a neuroplasticity-related common pathway for psychiatric illness;Frontiers in Drug Delivery;2024-09-13

2. Effect of ultrasound-mediated blood-spinal cord barrier opening on survival and motor function in females in an amyotrophic lateral sclerosis mouse model;eBioMedicine;2024-08

3. Safety and efficacy of arimoclomol in patients with early amyotrophic lateral sclerosis (ORARIALS-01): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial;The Lancet Neurology;2024-07

4. A disorder of consciousness rather than complete locked-in may be the final stage of ALS;2024-06-24

5. Navigating Neurodegenerative Disorders: A Comprehensive Review of Current and Emerging Therapies for Neurodegenerative Disorders;Journal of Neuroscience and Neurological Disorders;2024-04-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3